Who invested in Elypta

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$1.0Mraised across 1 round since 2023, from 1 source

Latest round: Grant, $1.0MMar 2023
Investors: 4

See who backed them

The rounds

Mar 2023
Grant$1.0M
Source recorded

Founders and team

From Elypta's own website: 1 founder, 20 on the team.

Jens NielsenChairman, Founder

Karl BergmanCEO
Johan VikströmChief Financial Officer
Volker LiebenbergChief Medical Officer
Andrea BomanVP Quality & Regulatory
Gabriel OrtizVP of Software Engineering
Karin MattssonVP of Research & Development
Anna AngelopoulouSenior Research Engineer
Davide TamburroPrincipal Research Scientist
Elin AlmstedtBoard Member
Eva PisaBoard Member
Flavia PlastinoResearch Scientist
Hannah ThielSenior Research Engineer
Hilja IbertBoard Member
Jonas JendiBoard Member
Laimei LundströmSenior Data Scientist
Liudmyla KorshunProduction Manager
Marianna MirabelliDirector of Clinical Development
Rena SiopiSenior Research Scientist

And 2 more on the team.

AdvisersFrancesco Gatto

Everyone who backed them

EISMEAInvestment firm1round

Chalmers Ventures ABVC firm1round

Norrsken VCAccelerator1round

Nina CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Elypta as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.